Medicine and Dentistry
Hematopoietic Stem Cell Transplantation
100%
Allogeneic Hematopoietic Stem Cell Transplantation
100%
Blood Group ABO Incompatibility
100%
Adverse Event
50%
Erythrocyte
50%
Blood Transfusion Reaction
50%
Conditioning
50%
Rituximab
50%
Stem Cell Transplant
50%
Stem Cell
50%
Peripheral Blood Stem Cell
50%
Fludarabine
50%
Melphalan
50%
Blood Group O
50%
Blood Group AB
50%
Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
ABO Incompatibility
100%
Anti-Jka
100%
Adverse Events
33%
Red Blood Cells
33%
Rituximab
33%
Conditioning Regimen
33%
White People
33%
Stem Cell Donor
33%
Progress Management
33%
Blood Group
33%
Unrelated Donor
33%
Fludarabine
33%
Melphalan
33%
Blood Group O
33%
Hemolytic Transfusion Reaction
33%
Peripheral Blood Stem Cell Transplantation
33%
Biochemistry, Genetics and Molecular Biology
Hematopoietic Stem Cell Transplantation
100%
Allogeneic Hematopoietic Stem Cell Transplantation
100%
Blood Group ABO Incompatibility
100%
Stem Cell
50%
Conditioning
50%
Stem Cell Transplant
50%
Melphalan
50%
Fludarabine
50%
Rituximab
50%
Blood Group O
50%
Delayed Hemolytic Transfusion Reaction
50%
Blood Group AB
50%
Immunology and Microbiology
Hematopoietic Stem Cell Transplantation
100%
Allogeneic Hematopoietic Stem Cell Transplantation
100%
Blood Group ABO Incompatibility
100%
Stem Cell
50%
Rituximab
50%
Stem Cell Transplant
50%
Peripheral Blood Stem Cell
50%
Conditioning
50%
Blood Group O
50%
Delayed Hemolytic Transfusion Reaction
50%
Blood Group AB
50%
Pharmacology, Toxicology and Pharmaceutical Science
Blood Group ABO Incompatibility
100%
Adverse Event
50%
Melphalan
50%
Rituximab
50%
Fludarabine
50%
Blood Transfusion Reaction
50%